KAMADA
Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders, and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations ...
Registered · April 18, 2016 · 79194198 ·